All Stories

  1. IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans

    Article • Nature Immunology, January 2026, Springer Science + Business Media

    Sandra Bos

  2. Longitudinal antibody profiling after dengue reveals distinct dynamics by antibody specificity over 18 months

    Article • August 2025, Cold Spring Harbor Laboratory Press

    Sandra Bos

  3. Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease

    Article • Cell Reports, May 2025, Elsevier

    Sandra Bos

  4. Post-Zika anti-NS1 serum IgA drives increased neutrophil functions in severe dengue disease

    Article • February 2025, Cold Spring Harbor Laboratory Press

    Sandra Bos

  5. Serotype-specific epidemiological patterns of inapparent versus symptomatic primary dengue virus infections: a 17-year cohort study in Nicaragua

    Article • The Lancet Infectious Diseases, October 2024, Elsevier

    Sandra Bos

  6. Complement-dependent virion lysis mediated by dengue-Zika virus cross-reactive antibodies correlates with protection from severe dengue disease

    Article • June 2024, Cold Spring Harbor Laboratory Press

    Sandra Bos

  7. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1

    Article • Science Translational Medicine, May 2024, American Association for the Advancement of Science

    Sandra Bos

  8. Inapparent primary infections reveal hidden serotype-specific epidemiological patterns and spectrum of infection outcome: a cohort study in Nicaragua

    Article • April 2024, Cold Spring Harbor Laboratory Press

    Sandra Bos

  9. Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

    Article • Nature Communications, January 2024, Springer Science + Business Media

    Sandra Bos

  10. Primary exposure to Zika virus increases risk of symptomatic dengue virus infection with serotypes 2, 3, and 4 but not serotype 1

    Article • November 2023, Cold Spring Harbor Laboratory Press

    Sandra Bos

  11. Phylodynamics of dengue virus 2 in Nicaragua leading up to the 2019 epidemic reveals a role for lineage turnover

    Article • BMC Ecology and Evolution, September 2023, Springer Science + Business Media

    Sandra Bos

  12. The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior immunity, and assay condition

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Sandra Bos

  13. Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection

    Article • Science Translational Medicine, June 2022, American Association for the Advancement of Science

    Sandra Bos

  14. Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling

    Article • Frontiers in Immunology, October 2020, Frontiers

    Sandra Bos

  15. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus

    Article • Current Opinion in Virology, August 2020, Elsevier

    Sandra Bos

  16. The Envelope Residues E152/156/158 of Zika Virus Influence the Early Stages of Virus Infection in Human Cells

    Article • Cells, November 2019, MDPI AG

    Sandra Bos

  17. A Chimeric Zika Virus between Viral Strains MR766 and BeH819015 Highlights a Role for E-glycan Loop in Antibody-mediated Virus Neutralization

    Article • Vaccines, June 2019, MDPI AG

    Sandra Bos

  18. The Roles of prM-E Proteins in Historical and Epidemic Zika Virus-mediated Infection and Neurocytotoxicity

    Article • Viruses, February 2019, MDPI AG

    Sandra Bos

  19. Subversion of the Heme Oxygenase-1 Antiviral Activity by Zika Virus

    Article • Viruses, December 2018, MDPI AG

    Sandra Bos

  20. Dengue: a growing threat requiring vaccine development for disease prevention

    Article • Pathogens and Global Health, August 2018, Taylor & Francis

    professor philippe Desprès, Sandra Bos

  21. Probing Molecular Insights into Zika Virus–Host Interactions

    Article • Viruses, May 2018, MDPI AG

    Sandra Bos

  22. Probing Molecular Insights of Zika Virus-Host Interactions

    Article • April 2018, MDPI AG

    Sandra Bos

  23. The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection in Human Cells

    Article • International Journal of Molecular Sciences, April 2018, MDPI AG

    Sandra Bos

  24. The structural proteins of epidemic and historical strains of Zika virus differ in their ability to initiate viral infection in human host cells

    Article • Virology, March 2018, Elsevier

    Sandra Bos

  25. Recombinant Zika NS1 Protein Secreted from Vero Cells Is Efficient for Inducing Production of Immune Serum Directed against NS1 Dimer

    Article • International Journal of Molecular Sciences, December 2017, MDPI AG

    Sandra Bos

  26. ClearColi BL21(DE3)-based expression of Zika virus antigens illustrates a rapid method of antibody production against emerging pathogens

    Article • Biochimie, November 2017, Elsevier

    Sandra Bos

  27. A robust method for the rapid generation of recombinant Zika virus expressing the GFP reporter gene

    Article • Virology, October 2016, Elsevier

    Sandra Bos